Skip to main content

Table 1 Demographic, lifestyle, complications and MCC in different functional status

From: Functional status and its related factors among stroke survivors in rehabilitation departments of hospitals in Shenzhen, China: a cross-sectional study

Characteristics

Total

Functional status

\({x}^{2}\)

P-value

n

%

Bedridden group

Domestic group

Community group

n

%

n

%

n

%

Type of stroke

        

5.77

0.056

  Ischemic

321

49.69

219

68.22

82

25.55

20

6.23

  

  Hemorrhagic

325

50.31

247

76.00

58

17.85

20

6.15

  

Sex

        

12.09

0.002

  Male

443

68.58

308

69.53

98

22.12

37

8.35

  

  Female

203

31.42

158

77.83

42

20.69

3

1.48

  

Age (year)

        

38.42

 < 0.001

  < 60

258

39.94

156

60.47

71

27.52

31

12.02

  

  ≥ 60

388

60.06

310

79.90

69

17.78

9

2.32

  

Duration (month)

          

  < 12

216

33.43

142

65.74

56

25.93

18

8.33

6.95

0.031

  ≥ 12

430

66.56

324

75.35

84

19.53

22

5.12

  

BMI (kg/m2)

        

21.94

0.005

  ≤ 18.4

65

10.42

55

84.62

9

13.85

1

1.54

  

  18.5–23.9

395

63.30

294

74.43

78

19.75

23

5.82

  

  24–27.9

143

22.92

88

61.54

44

30.77

11

7.69

  

  ≥ 28

21

3.36

10

47.62

8

38.01

3

14.29

  

Smoking

        

0.86

0.650

  Yes

50

7.99

39

78.00

9

18.00

2

4.00

  

  No

576

92.01

415

72.05

127

22.05

34

5.90

  

Alcohol consumption

        

4.66

0.097

  Yes

38

6.06

33

86.84

3

7.89

2

5.26

  

  No

589

93.94

422

71.65

132

22.41

35

5.94

  

Pulmonary infection

        

79.67

 < 0.001

  Yes

228

35.29

213

93.42

13

5.70

2

0.88

  

  No

418

64.71

253

60.53

127

30.38

38

9.09

  

Urinary tract infection

        

6.94

0.139

  Yes

59

9.20

51

86.21

7

12.07

1

1.72

  

  No

587

90.87

415

70.70

133

22.66

39

6.64

  

Deep venous thrombosis

        

8.21

0.017

  Yes

63

9.75

55

87.30

7

11.11

1

1.59

  

  No

583

90.25

411

70.50

133

22.81

39

6.69

  

Complications

        

65.20

 < 0.001

  0

319

49.40

186

58.31

102

31.97

31

9.72

  

  1

236

36.50

194

82.20

34

14.41

8

3.39

  

  ≥ 2

91

14.10

86

94.51

4

4.40

1

1.10

  

Hypertension

        

3.04

0.219

  Yes

480

74.30

339

70.63

112

23.33

29

6.04

  

  No

166

25.70

127

76.51

28

16.87

11

6.63

  

Cardiovascular disease

        

1.94

0.379

  Yes

117

18.11

86

73.50

27

23.08

4

3.42

  

  No

529

81.89

380

71.83

113

21.36

36

6.81

  

Diabetes

        

4.30

0.116

  Yes

190

29.46

142

74.74

42

22.11

6

3.16

  

  No

455

70.54

323

70.99

98

21.54

34

7.47

  

Hyperlipidemia

        

1.05

0.593

  Yes

60

9.29

41

68.33

16

26.67

3

5.00

  

  No

586

90.71

425

72.53

124

21.16

37

6.31

  

Hyperuricemia

        

1.97

0.374

  Yes

23

3.56

15

65.22

5

21.74

3

13.04

  

  No

623

96.44

451

72.39

135

21.67

37

5.94

  

Chronic obstructive pulmonary disease

        

2.99

0.224

  Yes

14

2.17

11

78.57

1

7.14

2

14.29

  

  No

632

97.83

455

71.99

139

21.99

38

6.01

  

Chronic renal insufficiency

        

0.54

0.765

  Yes

46

7.12

35

76.09

8

17.39

3

6.52

  

  No

600

92.88

431

71.83

132

22.00

37

6.17

  

Abnormal liver function

        

3.38

0.185

  Yes

27

4.18

23

85.19

2

7.41

2

7.41

  

  No

619

95.82

443

71.57

138

22.29

38

6.14

  

Chronic bronchitis

        

3.15

0.207

  Yes

19

2.94

17

89.50

2

10.50

0

0.00

  

  No

627

97.06

449

71.60

138

22.00

40

6.40

  

Multiple chronic conditions

        

8.00

0.104

  0

72

11.10

55

76.39

11

15.28

6

8.33

  

  1

215

33.30

142

66.05

57

26.51

16

7.44

  

  ≥ 2

359

55.60

269

74.93

72

20.06

18

5.01

  
  1. Significant p-values are bolded